Mazen Hanna,Ning Shan,Miranda L. Cheney,David R. Weyna
申请号：
US12321525
公开号：
US08124603B2
申请日:
2009.01.22
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The invention is directed to novel crystalline forms of meloxicam. These novel crystalline forms of meloxicam have improved bioavailability, an enhanced rate of dissolution and shorter time to Cmax in blood, as compared to pure meloxicam.
